Viridien
Short position disclosed on August 12, 2026.
5.32% of the capital sold short
7 disclosing funds
2,460 disclosures on record
Evolution of the disclosed total
0%2%4%6%
Oct 2025Jan 2026Apr 2026Jul 2026
January 7, 2013 today
Open positions
| Fund | Twelve months | % of capital | Over the year | Since |
|---|---|---|---|---|
| Capital Fund Management | 1.59% | +0.50 pt | July 31, 2026 | |
| Marshall Wace LLP | 0.80% | -0.39 pt | August 7, 2026 | |
| TWO Sigma Investments, LP | 0.64% | new | August 3, 2026 | |
| Citadel Advisors LLC | 0.61% | +0.01 pt | August 12, 2026 | |
| Walleye Capital LLC | 0.60% | new | August 7, 2026 | |
| Mirabella Financial Services LLP | 0.57% | unchanged | January 30, 2025 | |
| Tudor Capital Europe LLP | 0.51% | new | May 7, 2026 |
On the other side: the funds that hold Viridien Titelia
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| May 30, 2023 | Citadel Advisors LLC | 0.90% | July 5, 2023 |
| May 26, 2023 | Qube Research & Technologies Limited | 0.99% | March 4, 2024 |
| May 25, 2023 | Qube Research & Technologies Limited | 1.00% | March 4, 2024 |
| May 25, 2023 | Citadel Advisors LLC | 0.89% | July 5, 2023 |
| May 23, 2023 | Qube Research & Technologies Limited | 0.97% | March 4, 2024 |
| May 23, 2023 | Citadel Advisors LLC | 0.88% | July 5, 2023 |
| May 19, 2023 | Qube Research & Technologies Limited | 1.08% | March 4, 2024 |
| May 18, 2023 | Qube Research & Technologies Limited | 1.16% | March 4, 2024 |
| May 16, 2023 | Marshall Wace LLP | 2.37% | August 15, 2023 |
| May 15, 2023 | Qube Research & Technologies Limited | 1.21% | March 4, 2024 |
| May 12, 2023 | Marshall Wace LLP | 2.40% | August 15, 2023 |
| May 12, 2023 | Qube Research & Technologies Limited | 1.18% | March 4, 2024 |
| May 8, 2023 | Citadel Advisors LLC | 0.97% | July 5, 2023 |
| May 5, 2023 | Qube Research & Technologies Limited | 1.21% | March 4, 2024 |
| May 5, 2023 | Citadel Advisors LLC | 1.00% | July 5, 2023 |
| May 4, 2023 | Qube Research & Technologies Limited | 1.12% | March 4, 2024 |
| May 4, 2023 | Citadel Advisors LLC | 0.95% | July 5, 2023 |
| May 3, 2023 | Qube Research & Technologies Limited | 0.91% | March 4, 2024 |
| May 2, 2023 | Qube Research & Technologies Limited | 0.87% | March 4, 2024 |
| April 28, 2023 | Marshall Wace LLP | 2.33% | August 15, 2023 |
| April 28, 2023 | Citadel Advisors LLC | 1.10% | July 5, 2023 |
| April 26, 2023 | Marshall Wace LLP | 2.44% | August 15, 2023 |
| April 25, 2023 | Marshall Wace LLP | 2.51% | August 15, 2023 |
| April 25, 2023 | Citadel Advisors LLC | 1.01% | July 5, 2023 |
| April 24, 2023 | Qube Research & Technologies Limited | 0.93% | March 4, 2024 |
| April 21, 2023 | Citadel Advisors LLC | 0.90% | July 5, 2023 |
| April 21, 2023 | Qube Research & Technologies Limited | 0.87% | March 4, 2024 |
| April 19, 2023 | Citadel Advisors LLC | 0.84% | July 5, 2023 |
| April 19, 2023 | Qube Research & Technologies Limited | 0.73% | March 4, 2024 |
| April 19, 2023 | POINT72 Asset Management, L.P. | 0.49% | April 21, 2023 |
| April 18, 2023 | Citadel Advisors LLC | 0.77% | July 5, 2023 |
| April 18, 2023 | Qube Research & Technologies Limited | 0.68% | March 4, 2024 |
| April 17, 2023 | Qube Research & Technologies Limited | 0.74% | March 4, 2024 |
| April 17, 2023 | Citadel Advisors LLC | 0.68% | July 5, 2023 |
| April 14, 2023 | Marshall Wace LLP | 2.61% | August 15, 2023 |
| April 14, 2023 | Citadel Advisors LLC | 0.56% | July 5, 2023 |
| April 11, 2023 | POINT72 Asset Management, L.P. | 0.59% | April 21, 2023 |
| April 4, 2023 | Marshall Wace LLP | 2.57% | August 15, 2023 |
| March 31, 2023 | Marshall Wace LLP | 2.67% | August 15, 2023 |
| March 31, 2023 | POINT72 Asset Management, L.P. | 0.69% | April 21, 2023 |
| March 28, 2023 | Marshall Wace LLP | 2.72% | August 15, 2023 |
| March 27, 2023 | Marshall Wace LLP | 2.66% | August 15, 2023 |
| March 27, 2023 | Qube Research & Technologies Limited | 0.82% | March 4, 2024 |
| March 27, 2023 | POINT72 Asset Management, L.P. | 0.77% | April 21, 2023 |
| March 24, 2023 | Marshall Wace LLP | 2.50% | August 15, 2023 |
| March 24, 2023 | Qube Research & Technologies Limited | 0.97% | March 4, 2024 |
| March 22, 2023 | Marshall Wace LLP | 2.20% | August 15, 2023 |
| March 21, 2023 | Qube Research & Technologies Limited | 1.00% | March 4, 2024 |
| March 21, 2023 | POINT72 Asset Management, L.P. | 0.89% | April 21, 2023 |
| March 20, 2023 | POINT72 Asset Management, L.P. | 0.92% | April 21, 2023 |
Other companies sold short in France
- Ubisoft Entertainment 13.69% of the capital sold short
- Valeo 10.92% of the capital sold short
- Teleperformance 8.94% of the capital sold short
- FDJ United 6.67% of the capital sold short
- Renault 6.54% of the capital sold short
- Remy Cointreau 5.36% of the capital sold short
- Alstom 5.23% of the capital sold short
- Abivax 5.04% of the capital sold short
- Worldline 4.48% of the capital sold short
- Vusiongroup 4.08% of the capital sold short
- Forvia 4.06% of the capital sold short
- Publicis Groupe SA 3.38% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Viridien, source AMF, data as at August 12, 2026, https://www.quivad.com/action/viridien?page=14